Evaluation of CT scans in tardive dyskinesia

D. V. Jeste, R. L. Wagner, Daniel Weinberger, K. G. Rieth, R. J. Wyatt

Research output: Contribution to journalArticle

Abstract

In view of the inconclusive and conflicting reports on the neuropathology of tardive dyskinesia, the authors performed a CT scan study of patients with severe, long lasting dyskinesia and of a matched control group. They sought answers to two questions: First, is there caudate atrophy in tardive dyskinesia, similar to that in Huntington's chorea? This seemed likely because of several phenomenologic and pharmacologic similarities between the two conditions. Second, does brain damage predispose to tardive dyskinesia? If it did, one might find more evidence of structural abnormalities in patients with dyskinesia compared with controls matched for age and especially for length of neuroleptic treatment. The bifrontal bicaudate ratio was significantly smaller in Huntington's chorea patients than in subjects with tardive dyskinesia. A small bifrontal bicaudate ratio indicates caudate atrophy. There were no significant differences between CT scans of dyskinesia patients and those of matched psychiatric controls on any of the variables studied. In each group, CT scans of patients receiving either no neuroleptics or less than 100 mg/day of chlorpromazine equivalents did not differ significantly from those of patients who were receiving more than 100 mg/day of chlorpromazine equivalents.

Original languageEnglish (US)
Pages (from-to)247-248
Number of pages2
JournalAmerican Journal of Psychiatry
Volume137
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Dyskinesias
Huntington Disease
Chlorpromazine
Antipsychotic Agents
Atrophy
Psychiatry
Tardive Dyskinesia
Research Design
Control Groups
Brain
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Jeste, D. V., Wagner, R. L., Weinberger, D., Rieth, K. G., & Wyatt, R. J. (1980). Evaluation of CT scans in tardive dyskinesia. American Journal of Psychiatry, 137(2), 247-248.

Evaluation of CT scans in tardive dyskinesia. / Jeste, D. V.; Wagner, R. L.; Weinberger, Daniel; Rieth, K. G.; Wyatt, R. J.

In: American Journal of Psychiatry, Vol. 137, No. 2, 1980, p. 247-248.

Research output: Contribution to journalArticle

Jeste, DV, Wagner, RL, Weinberger, D, Rieth, KG & Wyatt, RJ 1980, 'Evaluation of CT scans in tardive dyskinesia', American Journal of Psychiatry, vol. 137, no. 2, pp. 247-248.
Jeste DV, Wagner RL, Weinberger D, Rieth KG, Wyatt RJ. Evaluation of CT scans in tardive dyskinesia. American Journal of Psychiatry. 1980;137(2):247-248.
Jeste, D. V. ; Wagner, R. L. ; Weinberger, Daniel ; Rieth, K. G. ; Wyatt, R. J. / Evaluation of CT scans in tardive dyskinesia. In: American Journal of Psychiatry. 1980 ; Vol. 137, No. 2. pp. 247-248.
@article{8cff1ee0177a4fdc95cece6742f7dc78,
title = "Evaluation of CT scans in tardive dyskinesia",
abstract = "In view of the inconclusive and conflicting reports on the neuropathology of tardive dyskinesia, the authors performed a CT scan study of patients with severe, long lasting dyskinesia and of a matched control group. They sought answers to two questions: First, is there caudate atrophy in tardive dyskinesia, similar to that in Huntington's chorea? This seemed likely because of several phenomenologic and pharmacologic similarities between the two conditions. Second, does brain damage predispose to tardive dyskinesia? If it did, one might find more evidence of structural abnormalities in patients with dyskinesia compared with controls matched for age and especially for length of neuroleptic treatment. The bifrontal bicaudate ratio was significantly smaller in Huntington's chorea patients than in subjects with tardive dyskinesia. A small bifrontal bicaudate ratio indicates caudate atrophy. There were no significant differences between CT scans of dyskinesia patients and those of matched psychiatric controls on any of the variables studied. In each group, CT scans of patients receiving either no neuroleptics or less than 100 mg/day of chlorpromazine equivalents did not differ significantly from those of patients who were receiving more than 100 mg/day of chlorpromazine equivalents.",
author = "Jeste, {D. V.} and Wagner, {R. L.} and Daniel Weinberger and Rieth, {K. G.} and Wyatt, {R. J.}",
year = "1980",
language = "English (US)",
volume = "137",
pages = "247--248",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "2",

}

TY - JOUR

T1 - Evaluation of CT scans in tardive dyskinesia

AU - Jeste, D. V.

AU - Wagner, R. L.

AU - Weinberger, Daniel

AU - Rieth, K. G.

AU - Wyatt, R. J.

PY - 1980

Y1 - 1980

N2 - In view of the inconclusive and conflicting reports on the neuropathology of tardive dyskinesia, the authors performed a CT scan study of patients with severe, long lasting dyskinesia and of a matched control group. They sought answers to two questions: First, is there caudate atrophy in tardive dyskinesia, similar to that in Huntington's chorea? This seemed likely because of several phenomenologic and pharmacologic similarities between the two conditions. Second, does brain damage predispose to tardive dyskinesia? If it did, one might find more evidence of structural abnormalities in patients with dyskinesia compared with controls matched for age and especially for length of neuroleptic treatment. The bifrontal bicaudate ratio was significantly smaller in Huntington's chorea patients than in subjects with tardive dyskinesia. A small bifrontal bicaudate ratio indicates caudate atrophy. There were no significant differences between CT scans of dyskinesia patients and those of matched psychiatric controls on any of the variables studied. In each group, CT scans of patients receiving either no neuroleptics or less than 100 mg/day of chlorpromazine equivalents did not differ significantly from those of patients who were receiving more than 100 mg/day of chlorpromazine equivalents.

AB - In view of the inconclusive and conflicting reports on the neuropathology of tardive dyskinesia, the authors performed a CT scan study of patients with severe, long lasting dyskinesia and of a matched control group. They sought answers to two questions: First, is there caudate atrophy in tardive dyskinesia, similar to that in Huntington's chorea? This seemed likely because of several phenomenologic and pharmacologic similarities between the two conditions. Second, does brain damage predispose to tardive dyskinesia? If it did, one might find more evidence of structural abnormalities in patients with dyskinesia compared with controls matched for age and especially for length of neuroleptic treatment. The bifrontal bicaudate ratio was significantly smaller in Huntington's chorea patients than in subjects with tardive dyskinesia. A small bifrontal bicaudate ratio indicates caudate atrophy. There were no significant differences between CT scans of dyskinesia patients and those of matched psychiatric controls on any of the variables studied. In each group, CT scans of patients receiving either no neuroleptics or less than 100 mg/day of chlorpromazine equivalents did not differ significantly from those of patients who were receiving more than 100 mg/day of chlorpromazine equivalents.

UR - http://www.scopus.com/inward/record.url?scp=0018862844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018862844&partnerID=8YFLogxK

M3 - Article

C2 - 6101530

AN - SCOPUS:0018862844

VL - 137

SP - 247

EP - 248

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 2

ER -